Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
ClinicalTrials.gov study NCT07022483. IPD Sharing: YES. Countries: 5. Publications: 0.
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced
ClinicalTrials.gov study NCT03584009. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT01269346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT04249622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03786094. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
ClinicalTrials.gov study NCT01649271. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens
ClinicalTrials.gov study NCT04989816. IPD Sharing: YES. Countries: 1. Publications: 0.
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer
ClinicalTrials.gov study NCT02827877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT02003209. IPD Sharing: Not stated. Countries: 2. Publications: 0.
XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01777945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
ClinicalTrials.gov study NCT00618657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer
ClinicalTrials.gov study NCT02751528. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stag
ClinicalTrials.gov study NCT06733233. IPD Sharing: YES. Countries: 0. Publications: 5.
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
ClinicalTrials.gov study NCT04430738. IPD Sharing: YES. Countries: 2. Publications: 0.
Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
ClinicalTrials.gov study NCT04609540. IPD Sharing: NO. Countries: 0. Publications: 0.
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
ClinicalTrials.gov study NCT07198724. IPD Sharing: YES. Countries: 1. Publications: 0.
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer
ClinicalTrials.gov study NCT00670982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
ClinicalTrials.gov study NCT05013554. IPD Sharing: YES. Countries: 6. Publications: 0.
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer
ClinicalTrials.gov study NCT03132467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine
ClinicalTrials.gov study NCT06247995. IPD Sharing: YES. Countries: 13. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.